These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30426218)

  • 1. Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome.
    Gasongo G; Greenbaum LA; Niel O; Kwon T; Macher MA; Maisin A; Baudouin V; Dossier C; Deschênes G; Hogan J
    Pediatr Nephrol; 2019 Apr; 34(4):679-684. PubMed ID: 30426218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rare Disorder with Common Clinical Presentation: Neonatal Bartter Syndrome.
    Hussain S; Tarar SH; Al-Muhaizae M
    J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S58-60. PubMed ID: 25933468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bartter syndrome: a new therapeutic approach].
    Mendonça M; Pinheiro A; Castro I
    Acta Med Port; 2011 Dec; 24 Suppl 3():671-4. PubMed ID: 22856410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical examination of mother's urine is useful for prenatal diagnosis of Bartter syndrome.
    Matsushita Y; Suzuki Y; Oya N; Kajiura S; Okajima K; Uemura O; Suzumori K
    Prenat Diagn; 1999 Jul; 19(7):671-3. PubMed ID: 10419618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bartter syndrome in a neonate: early treatment with indomethacin.
    Mourani CC; Sanjad SA; Akatcherian CY
    Pediatr Nephrol; 2000 Feb; 14(2):143-5. PubMed ID: 10684365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic hypercalciuria associated with hyperreninemia and high urinary prostaglandin E.
    Houser M; Zimmerman B; Davidman M; Smith C; Sinaiko A; Fish A
    Kidney Int; 1984 Aug; 26(2):176-82. PubMed ID: 6389955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extreme example of the neonatal form of Bartter's syndrome.
    Williams MP; Jones CL; Johnstone LM; Walker RG; McCredie DA; Powell HR
    Pediatr Nephrol; 1996 Aug; 10(4):496-7. PubMed ID: 8865251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Reinalter SC; Jeck N; Brochhausen C; Watzer B; Nüsing RM; Seyberth HW; Kömhoff M
    Kidney Int; 2002 Jul; 62(1):253-60. PubMed ID: 12081585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bartter syndrome in two siblings--antenatal and neonatal observations.
    Proesmans W; Devlieger H; Van Assche A; Eggermont E; Vandenberghe K; Lemmens F; Sieprath P; Lijnen P
    Int J Pediatr Nephrol; 1985; 6(1):63-70. PubMed ID: 3888887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive acetazolamide therapy for the treatment of Bartter syndrome.
    Mazaheri M; Assadi F; Sadeghi-Bojd S
    Int Urol Nephrol; 2020 Jan; 52(1):121-128. PubMed ID: 31820361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter syndrome-like phenotype in a patient with type 2 diabetes mellitus.
    Kumar R; Shreshta N; Samdarshi S; Chauhan P
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of Bartter syndrome with indomethacin].
    Ploier R; Tulzer W; Fink M; Bohrn E
    Padiatr Padol; 1981; 16(1):81-92. PubMed ID: 7017552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Bartter syndrome. Unsolved issue.
    Nascimento CL; Garcia CL; Schvartsman BG; Vaisbich MH
    J Pediatr (Rio J); 2014; 90(5):512-7. PubMed ID: 24878005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin.
    Kornerup HJ; Pedersen EB; Petersen VP
    Acta Med Scand; 1978; 204(3):235-9. PubMed ID: 696424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in mice is associated with severe polyuria and a urea-selective concentrating defect without hyperreninemia.
    Kemter E; Rathkolb B; Bankir L; Schrewe A; Hans W; Landbrecht C; Klaften M; Ivandic B; Fuchs H; Gailus-Durner V; Hrabé de Angelis M; Wolf E; Wanke R; Aigner B
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1405-15. PubMed ID: 20219826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bartter's syndrome in Arabic children: review of 13 cases.
    Abdel-al YK; Badawi MH; Yaeesh SA; Habib YQ; al-Khuffash FA; al-Ghanim MM; al-Najidi AK
    Pediatr Int; 1999 Jun; 41(3):299-303. PubMed ID: 10365582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.